ClinicalTrials.Veeva

Menu

Soluble Dietary Fibres in the Prevention of Type 2 Diabetes Mellitus

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Completed

Conditions

Type 2 Diabetes Mellitus
Obesity

Treatments

Other: Polydextrose and soluble gluco fibre

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01163006
MEC 09-3-084

Details and patient eligibility

About

Controlling the glycemic impact of foodstuffs (by reducing the glycemic load of the diet by using soluble dietary fibres) may reduce the glycemic or insulinemic response. This may in turn result in a reduced inhibition of postprandial fat oxidation rate and a lower plasma triacylglycerol concentration A higher postprandial fat oxidation may result in less lipid accumulation in non-adipose tissue thereby improving insulin sensitivity and the metabolic profile in the longer term.

Enrollment

60 estimated patients

Sex

All

Ages

30 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Overweight men and women

Exclusion criteria

  • regular smokers, athletes, diabetes mellitus

Trial design

60 participants in 4 patient groups, including a placebo group

polydextrose
Experimental group
Treatment:
Other: Polydextrose and soluble gluco fibre
soluble glucofibre
Experimental group
Treatment:
Other: Polydextrose and soluble gluco fibre
isocaloric dietary control
Placebo Comparator group
Treatment:
Other: Polydextrose and soluble gluco fibre
full caloric control
Placebo Comparator group
Treatment:
Other: Polydextrose and soluble gluco fibre

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems